Methodology
Multiplex Plymerase Chain Reaction; Massively Parallel Sequencing
Synonyms
CF Mutation Screen; Cystic Fibrosis Mutation Screen; CFTR Screen; CF Carrier Screen; CF Screen; Cystic Fibrosis Carrier Screen
Specimen Type
Whole Blood
Performing Lab
Quest Diagnostics San Juan Capistrano
Epic ID
LAB01192
Lab Test Days
Daily
Standard TAT
7 Days
Collection Information
Specimen Required
3-4 mL Whole Blood
Container Type
Lavender (EDTA)
Collection Instructions
Whole blood collected in an EDTA (royal blue-top), ACD Solution A/B (yellow-top) tube, sodium heparin (green-top), lithium heparin (green-top) is also acceptable. 2 mL Saliva in Oragene DNA self-collection kit is also acceptable. Indicate ethnicity of the patients.
Processing Information - Lab Use Only
Transport Temperature
Refrigerate-OK/Ambient-OK
Specimen Stability
Room Temp: 8 Days (14 Days for Saliva); Refrigerated: 8 Days (14 Days for Saliva); Frozen: Unacceptable
Test Volume Required
4 mL Whole Blood or 2 mL Saliva
Minimum Test Volume
3 mL Whole Blood or 2 mL Saliva
Included Tests
General screen for carrier status & assessment of CF risk. This test will identify approx. 90% of Cystic Fibrosis mutations in the Caucasian population, and 97% in the Ashkenazi Jewish population.
Comments
Insurance authorization is required prior to draw for outpatients. Ok to send on inpatients. No special send out forms needed.
CPT Codes
81220
Revised
06-22-21